OA01.06 First-Line Chemotherapy With or Without Tislelizumab for Extensive-Stage Small Cell Lung Cancer: RATIONALE-312 Phase 3 Study

Y. Cheng, Y. Fan, Y. Zhao, D. Huang, X. Li,P. Zhang,M. Kang, N. Yang,D. Zhong, Z. Wang, Y. Yu, Y. Zhang, J. Zhao,T. Qin, C. Chen,S. Leaw, W. Zheng, Y. Song

Journal of Thoracic Oncology（2023）

引用 0|浏览9

暂无评分

关键词

small cell lung cancer,cell lung cancer,tislelizumab,lung cancer,first-line,extensive-stage

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要